Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. TVGN
TVGN logo

TVGN Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Tevogen Bio Holdings Inc (TVGN) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
8.300
1 Day change
12.47%
52 Week Range
75.500
Analysis Updated At
2026/04/17
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Tevogen Bio Holdings Inc (TVGN) is not a good buy for a beginner investor with a long-term strategy at this time. The stock is facing negative sentiment due to a recent reverse stock split, weak financial performance, and lack of positive catalysts. Additionally, there are no strong trading signals or significant institutional or insider activity to support a buy decision.

Technical Analysis

The MACD is positive but contracting, RSI is neutral at 73.339, and moving averages are converging, indicating no clear trend. The stock is trading near its resistance level (R1: 6.54) in pre-market, with a pre-market price of 6.22, down 2.20%.

Positive Catalysts

  • NULL identified. There are no recent news or events driving positive sentiment for the stock.

Neutral/Negative Catalysts

  • The recent 50:1 reverse stock split is perceived negatively by the market, and analysts expect additional near-term trading pressure. Financial performance is weak, with significant YoY declines in net income (-48.80%) and EPS (-46.71%).

Financial Performance

In Q4 2025, revenue remained at 0 with no growth. Net income dropped to -4,817,717 (-48.80% YoY), and EPS fell to -2.35 (-46.71% YoY). Gross margin remained at 0 with no improvement.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

D. Boral Capital downgraded the stock to Hold from Buy, citing the negative implications of the reverse stock split and weaker capital markets position.

Wall Street analysts forecast TVGN stock price to rise
Analyst Rating
0
Wall Street analysts forecast TVGN stock price to rise
Buy
Hold
Sell
0
Current: 7.380
sliders
Low
0
Averages
0
High
0
0
Current: 7.380
sliders
Low
0
Averages
0
High
0
Boral Capital
D. Boral
Buy -> Hold
downgrade
AI Analysis
2026-03-04
Reason
Boral Capital
D. Boral
Price Target
AI Analysis
2026-03-04
downgrade
Buy -> Hold
Reason
D. Boral Capital downgraded Tevogen to Hold from Buy without a price target citing the company's 50:1 reverse stock split. While the move is largely technical in nature, reverse stock splits are often perceived negatively by the market, and historically, stocks tend to trade lower following such events, the analyst tells investors in a research note. D. Boral believes the split will add additional near-term trading pressure and reflects Tevogen's weaker capital markets position.
D. Boral Capital
Jason Kolbert
Strong Buy
Maintains
$10
2025-04-21
Reason
D. Boral Capital
Jason Kolbert
Price Target
$10
2025-04-21
Maintains
Strong Buy
Reason

People Also Watch